SeaStar Medical Holding Corporation (ICU)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Eric Schlorff | CEO, President & Executive Director | 420k | -- | 1973 |
| Mr. David A. Green CPA, M.B.A. | Chief Financial Officer | 375.6k | -- | 1963 |
| Colonel Kevin Chung FACP, M.D. | Chief Medical Officer | 352.8k | -- | 1973 |
| Dr. H. David Humes M.D. | Co-Founder and Managing Director | 135.71k | -- | -- |
| Mr. Tom Mullen | Vice President of Operations & Product Development | -- | -- | -- |
| Mr. Tim Varacek | Senior VP of Commercial & Business Operations | -- | -- | -- |
| Mr. Sai P. Iyer Ph.D. | Senior Vice President of Medical Affairs & Research | -- | -- | -- |
SeaStar Medical Holding Corporation
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 19
Description
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
Corporate Governance
Upcoming Events
May 14, 2025 at 8:00 PM UTC
SeaStar Medical Holding Corporation Earnings Date